The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / CDC Advisers Consider Boosters for Immune-Compromised Americans

CDC Advisers Consider Boosters for Immune-Compromised Americans

July 26, 2021 • By Julie Steenhuysen

  • Tweet
  • Email
Print-Friendly Version / Save PDF

CHICAGO (Reuters)—Advisers to the U.S. Centers for Disease Control & Prevention will consider evidence suggesting that a booster dose of COVID-19 vaccines could increase protection among people with compromised immune systems.

You Might Also Like
  • CDC Says Fully Vaccinated People Can Gather Unmasked with Others Indoors
  • Check It Out: Understanding Immune-Related Adverse Events from Immune Checkpoint Inhibitors
  • Japan PM’s Advisers Urge Annual Review of Drug Prices

Data presented ahead of the July 22 meeting noted that people with compromised immune systems have a reduced antibody response following the recommended primary vaccination series compared with healthy individuals.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Emerging data suggest that an additional COVID-19 vaccine dose in immunocompromised people enhances antibody response and increases the proportion who respond,” slides released ahead of the meeting showed. 1

The committee is not scheduled to vote on a recommendation for whether to administer additional doses. That could be decided at a later meeting.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In small studies, short-term side effects from a third dose of mRNA vaccines—such as those made by BioNTech/Pfizer Inc. or Moderna Inc—were about the same as those seen with the first two doses, the CDC said in its presentation.

An estimated 2.7% of U.S. adults live with weakened immune systems, according to the CDC presentation, based on data from 2013. The group includes people living with HIV/AIDS, cancer and people with organ transplants or autoimmune disease who take drugs to dampen their immune response.

Those individuals are at increased risk of severe disease and death from COVID-19.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Last week, Israel began administering third doses of the Pfizer/BioNTech vaccine to immunocompromised people, including those who have had heart, lung, kidney or liver transplants and cancer patients receiving chemotherapy.

Some experts believe the CDC is nearing a similar recommendation in the U.S.

The CDC has warned individuals with weakened immune systems to take precautions even if they are fully vaccinated against COVID-19.

The virus not only poses an extra health risk to the immunocompromised, but because it takes longer for these individuals to clear the virus, scientists believe infections could result in new variants as the virus continues to replicate unchecked, which some studies have shown.


Reference

  1. ACIP presentation slides: July 22, 2021, meeting. CDC.gov. 2021 Jul 22.

Filed Under: Drug Updates Tagged With: CDC, Centers for Disease Control and Prevention, COVID-19, vaccines

You Might Also Like:
  • CDC Says Fully Vaccinated People Can Gather Unmasked with Others Indoors
  • Check It Out: Understanding Immune-Related Adverse Events from Immune Checkpoint Inhibitors
  • Japan PM’s Advisers Urge Annual Review of Drug Prices
  • After COVID-19-Associated MIS-C, Immune Changes Resolve

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)